Yuyu Pharma, Inc.

KOSE:A000220 株式レポート

時価総額：₩69.0b

Yuyu Pharma マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Robert Yu

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間4.6yrs
CEOの所有権26.6%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Unpleasant Surprises Could Be In Store For Yuyu Pharma, Inc.'s (KRX:000220) Shares

Nov 13
Unpleasant Surprises Could Be In Store For Yuyu Pharma, Inc.'s (KRX:000220) Shares

Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Aug 24
Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance

Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Aug 07
Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now

Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Apr 02
Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden

Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

Mar 08
Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?

The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

Feb 10
The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More

We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Jan 07
We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide

Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Dec 20
Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly

Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

Dec 03
Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?

CEO（最高経営責任者

Robert Yu

4.6yrs

在職期間

Mr. Wonsang Yu, also known as Robert, has been President and Chief Executive Officer of Yuyu Pharma, Inc. since April 6, 2020 and served as its Vice President. Prior to joining Yuyu Pharma in 2008, Mr. Yu...